Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Drug Omega 3 · 1 trial · 1 indication
Area under the plasma concentration curve versus time curve (AUC0-tau) versus time curve (AUC0-tau) for both treatments measured over the 24 hour period on day 1 and day 14 \[ Time Frame: 14 days \]
| Arm | Type | Description |
|---|---|---|
| Drug Omega 3 | EXPERIMENTAL | 4g (4 capsules) once a day, administered with food Other name MAT9001 |
| Drug Omega 3 Comparator | ACTIVE_COMPARATOR | 4g (4 capsules) once a day, administered with food Other name Omega 3 Active Comparator |
| Name | Type | Description |
|---|---|---|
| Drug Omega 3 | DRUG | 4 g (4 capsules) once a day, administered with food |
| Drug Omega-3 Comparator | DRUG | 4 g (4 capsules) once a day, administered with food |
Inclusion Criteria: Subjects must fulfil all of the following inclusion criteria to be eligible for participation in the study, unless otherwise specified: 1. Adult male or female subject, 18-70 years of age, inclusive. 2. Light- or non-smoking, male and female subjects, 18 to 70 years of age. Not...
Drug Omega 3 is an investigational small molecule being developed for hypertriglyceridemia, a condition characterized by elevated levels of triglycerides in the blood. It is currently in Phase 1 clinical development.
Drug Omega 3 is being developed by Matinas Biopharma Holdings, Inc., a biopharmaceutical company traded on the stock exchange under the ticker symbol MTNB.
Drug Omega 3 is in Phase 1 clinical development. It is an investigational drug and has not been approved by regulatory authorities. A Phase 1 study has been completed.
Drug Omega 3 has one completed Phase 1 clinical trial, identified as NCT02310022, titled 'A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules'. This trial enrolled 48 participants with hypertriglyceridemia in Canada.
Drug Omega 3 is a formulation of omega-3, specifically designed as one gram capsules. The clinical trial compared two formulations of these omega-3 capsules in patients with hypertriglyceridemia.